O'Rourke & Company’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $502K | Sell |
2,703
-56
| -2% | -$10.4K | 0.23% | 91 |
|
|
2025
Q1 | $578K | Sell |
2,759
-81
| -3% | -$17K | 0.29% | 76 |
|
|
2024
Q4 | $505K | Sell |
2,840
-76
| -3% | -$13.5K | 0.25% | 82 |
|
|
2024
Q3 | $576K | Buy |
2,916
+3
| +0.1% | +$592 | 0.29% | 74 |
|
|
2024
Q2 | $500K | Buy |
2,913
+3
| +0.1% | +$515 | 0.28% | 72 |
|
|
2024
Q1 | $530K | Buy |
2,910
+3
| +0.1% | +$546 | 0.31% | 68 |
|
|
2023
Q4 | $451K | Buy |
2,907
+7
| +0.2% | +$1.09K | 0.29% | 72 |
|
|
2023
Q3 | $432K | Buy |
2,900
+7
| +0.2% | +$1.04K | 0.32% | 64 |
|
|
2023
Q2 | $390K | Sell |
2,893
-27
| -0.9% | -$3.64K | 0.27% | 79 |
|
|
2023
Q1 | $465K | Buy |
2,920
+6
| +0.2% | +$955 | 0.35% | 66 |
|
|
2022
Q4 | $471K | Buy |
2,914
+241
| +9% | +$39K | 0.37% | 63 |
|
|
2022
Q3 | $359K | Sell |
2,673
-20
| -0.7% | -$2.69K | 0.31% | 75 |
|
|
2022
Q2 | $412K | Sell |
2,693
-110
| -4% | -$16.8K | 0.35% | 69 |
|
|
2022
Q1 | $454K | Buy |
2,803
+145
| +5% | +$23.5K | 0.31% | 72 |
|
|
2021
Q4 | $360K | Buy |
+2,658
| New | +$360K | 0.24% | 82 |
|